Log in to save to my catalogue

The NF1 gene in tumor syndromes and melanoma

The NF1 gene in tumor syndromes and melanoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5413358

The NF1 gene in tumor syndromes and melanoma

About this item

Full title

The NF1 gene in tumor syndromes and melanoma

Author / Creator

Publisher

New York: Elsevier Inc

Journal title

Laboratory investigation, 2017-02, Vol.97 (2), p.146-157

Language

English

Formats

Publication information

Publisher

New York: Elsevier Inc

More information

Scope and Contents

Contents

Activation of the RAS/MAPK pathway is critical in melanoma. Melanoma can be grouped into four molecular subtypes based on their main genetic driver: BRAF-mutant, NRAS-mutant, NF1-mutant, and triple wild-type tumors. The NF1 protein, neurofibromin 1, negatively regulates RAS proteins through GTPase activity. Germline mutations in NF1 cause neurofibr...

Alternative Titles

Full title

The NF1 gene in tumor syndromes and melanoma

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5413358

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5413358

Other Identifiers

ISSN

0023-6837

E-ISSN

1530-0307

DOI

10.1038/labinvest.2016.142

How to access this item